CALGARY, ALBERTA--(Marketwire - Nov. 13, 2007) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) is pleased to announce the appointment of Dr. Francesco Bellini, Chairman, President and CEO of Neurochem Inc., an industry leader in the development of therapeutic drugs for the Central Nervous System, to its Board of Directors.
